MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

MDT

95.31

-1.26%↓

VEEV

287.1

-0.28%↓

A

139.44

+0.99%↑

HQY

92.23

-1.52%↓

TLRY

1.67

+5.03%↑

Search

CorMedix Inc

Cerrado

SectorSanidad

10.56 0.19

Resumen

Variación precio

24h

Actual

Mínimo

10.49

Máximo

10.9

Métricas clave

By Trading Economics

Ingresos

-816K

20M

Ventas

655K

40M

P/B

Media del Sector

13.564

36.442

BPA

0.28

Margen de beneficios

49.898

Empleados

64

EBITDA

-297K

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+89.75% upside

Dividendos

By Dow Jones

Próximas Ganancias

29 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-95M

826M

Apertura anterior

10.37

Cierre anterior

10.56

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

166 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 oct 2025, 23:25 UTC

Principales Movimientos del Mercado

Salesforce Rises on New FY30 Financial Targets

15 oct 2025, 18:52 UTC

Ganancias
Principales Movimientos del Mercado

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 oct 2025, 18:30 UTC

Adquisiciones, fusiones, absorciones

Constellation Software to Buy U.K.'s Tecvia Holding

15 oct 2025, 17:19 UTC

Adquisiciones, fusiones, absorciones

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 oct 2025, 17:11 UTC

Adquisiciones, fusiones, absorciones

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 oct 2025, 23:48 UTC

Charlas de Mercado

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 oct 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 oct 2025, 22:37 UTC

Charlas de Mercado

Economic Stars Are Aligning for RBA -- Market Talk

15 oct 2025, 21:44 UTC

Ganancias

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 oct 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 oct 2025, 20:44 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 oct 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 oct 2025, 20:34 UTC

Ganancias

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 oct 2025, 20:17 UTC

Adquisiciones, fusiones, absorciones

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 oct 2025, 19:06 UTC

Ganancias

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 oct 2025, 19:04 UTC

Charlas de Mercado

Oil Futures Post Back-to-Back Losses -- Market Talk

15 oct 2025, 18:46 UTC

Charlas de Mercado

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 oct 2025, 18:23 UTC

Ganancias

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 oct 2025, 17:37 UTC

Adquisiciones, fusiones, absorciones

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 oct 2025, 17:34 UTC

Charlas de Mercado

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 oct 2025, 16:57 UTC

Ganancias

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 oct 2025, 16:51 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Doesn't Disclose Financial Details

15 oct 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 oct 2025, 16:49 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 oct 2025, 16:48 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 oct 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

EssilorLuxottica Buys Ikerian

15 oct 2025, 16:34 UTC

Charlas de Mercado

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

89.75% repunte

Estimación a 12 Meses

Media 20 USD  89.75%

Máximo 22 USD

Mínimo 17 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

166 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
help-icon Live chat